Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer

Laboratory Investigation

Volumn 77, Issue 4, 1997, Pages 345-355

  Nielsen, Boye Schnack ^a,b   Sehested, Maxwell ^a   Kjeldsen, Lars ^a   Borregaard, Niels ^a   Rygaard, Joørgen ^a   Danø, Keld ^a  

^a Kommunehospitalet ^*  (Denmark)

^b FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; GELATINASE B;

ARTICLE; BREAST CANCER; CELLULAR DISTRIBUTION; ENZYME ASSAY; ENZYME LOCALIZATION; ENZYME SYNTHESIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOLECULAR WEIGHT; NEUTROPHIL; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACTINS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COLLAGENASES; CONNECTIVE TISSUE CELLS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MELANOMA; MUSCLE, SMOOTH, VASCULAR; RNA, MESSENGER; VON WILLEBRAND FACTOR;

EID: 0030661882     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, and Chambon P (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704.
2. Bianchi E, Cohen RL, Dai A, Thor AT, Shuman MA, and Smith HS (1995). Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer. Int J Cancer 60:597-603.
3. Bianchi E, Cohen RL, Thor AT, Todd RF, Mizukami IF, Lawrence DA, Ljung BM, Shuman MA, and Smith HS (1994). The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 54:861-866.
4. Blasi F, Vassalli JD, and Danø K (1987). Urokinase-type plasminogen activator: Proenzyme, receptor, and inhibitors. J Cell Biol 104:801-804.
5. Borregaard N, Sehested M, Nielsen BS, Sengeløv H, and Kjeldsen L (1995). Biosynthesis of granule proteins in normal human bone marrow cells: Gelatinase is a marker of terminal neutrophil differentiation. Blood 85:812-817.
6. Byrne JA, Tomasetto C, Rouyer N, Bellocq JP, Rio MC, and Basset P (1995). The tissue inhibitor of metalloproteinases-3 gene in breast carcinoma: Identification of multiple polyadenylation sites and a stromal pattern of expression. Mol Med 1:418-427.
7. Cao J, Sato H, Takino T, and Seiki M (1995). The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for progelatinase A activation. J Biol Chem 270:801-804.
8. D'Amore PA (1992). Capillary growth: A two-cell system. Semin Cancer Biol 3:49-56.
9. Daneø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, and Skriver L (1985). Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44:139-266.
10. Danø K, Behrendt N, Brünner N, Ellis V, Ploug M, and Pyke C (1994). The urokinase receptor: Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 8:189-203.
11. Danø K, Grøndahl-Hansen J, Eriksen J, Schnack Nielsen B, Romer J, and Pyke C (1993). The receptor for urokinase plasminogen activator: Stromal cell involvement in extracellular proteolysis during cancer invasion. In: Barret AJ and Bond J, editors. Proteolysis and protein turnover. London: Portland Press, 239-245.
12. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, and Balkwill FR (1993a). Activity of type IV collagenases in benign and in malignant breast disease. Br J Cancer 67:1126-1131.
13. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, and Balkwill F (1993b). Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 52:5365-5369.
14. Falini B, Flenghi L, Pileri S, Gambacorta M, Bigerna B, Durkop H, Eitelbach F, Thiele J, Pacini R, Cavaliere A, Martelli M, Cardarelli N, Sabattinin E, Poggi S, and Stein H (1993). PG-M1: A new monoclonal antibody directed against a fixative resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 142:1359-1372.
15. Fisher C, Gilbertson Beadling S, Powers EA, Petzold G, Poorman R, and Mitchell MA (1994). Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 162:499-510.
16. Folkman J (1975). Tumor angiogenesis. Adv Cancer Res 43:175-203.
17. Fridman R, Toth M, Pena D, and Mobashery S (1995). Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55:2548-2555.
18. He C, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, and Goldberg GI (1989). Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 86:2632-2636.
19. Heppner KJ, Matrisian LM, Jensen RA, and Rodgers WH (1996). Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149:273-282.
20. Hewitt RE and Danø K (1996). Stromal cell expression of components of matrix degrading protease systems in human cancer. Enzyme Protein 49:163-173.
21. Hibbs MS, Hasty KA, Seyer JM, Kang AH, and Mainardi CL (1985). Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 260:2493-2500.
22. Hsu S-M, Raine L, and Fanger H (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
23. Kjeldsen L, Bjerrum OW, Askaa J, and Borregaard N (1992a). Subcellular localization and release of human neutrophil gelatinase, confirming the existence of a separate gelatinase-containing granule. Biochem J 287:603-610.
24. Kjeldsen L, Bjerrum OW, Johnsen HD, Sehested M, and Borregaard N (1992b). Human neutrophil gelatinase: A marker for circulating blood neutrophils. purification and quantifocation by enzyme linked immunosorbent assay. Eur J Haematol 49:180-191.
25. Kjeldsen L, Johnsen AH, Sengeløv H, and Borregaard N (1993). Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268:10425-10432.
26. Liotta LA, Steeg PS, and Stetler-Stevenson WG (1991). Cancer, metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327-336.
27. Lund LR, Rømer J, Thomasset N, Solberg H, Pyke C, Bissel M, Danø K, and Werb Z (1996). Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways. Development 122: 181-193.
28. Matrisian LM (1990). Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121-125.
29. Mignatti P and Rifkin DB (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161-195.
30. Nehls V, Denzer K, and Drenckhahn D (1992). Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 270:469-474.
31. Nehls V and Drenckhahn D (1991). Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J Cell Biol 113:147-154.
32. Nehls V and Drenckhahn D (1993). The versatility of microvascular pericytes: From mesenchyme to smooth muscle? Histochemistry 99:1-12.
33. Nehls V and Drenckhahn D (1995). A microcarrier-based cocultivation system for the investigation of factors and cells involved in angiogenesis in three-dimensional fibrin matrices in vitro. Histochem Cell Biol 104:459-466.
34. Nielsen BS, Sehested M, Timshel S, Pyke C, and Danø K (1996a). Messenger RNA for urokinase plasminogen activator (uPA) is expressed in myofibroblasts adjacent to cancer cells in human breast cancer. Lab Invest 74:168-177.
35. Nielsen BS, Timshel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N, and Danø K (1996b). 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 65:57-62.
36. Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, and Basset P (1995). Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92:2730-2734.
37. Pepper MS, Montesano R, Mandriota SJ, Orci L, and Vassalli JD (1996). Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49:138-162.
38. Pepper MS, Sappino AP, Stocklin R, Montesano R, Orci L, and Vassalli JD (1993). Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 122: 673-684.
39. Pepper MS, Vassalli JD, Montesano R, and Orci L (1987). Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol 105:2535-2541.
40. Poulsom R, Hanby AM, Pignatelli M, Jeffery RE, Longcroft JM, Rogers L, and Stamp GW (1993). Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 46:429-436.
41. Pyke C, Ralfkiær E, Huhtala P, Hurskainen T, Danø K, and Tryggvason K (1992). Localization of messenger RNA for Mr 72:000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 52:1336-1341.
42. Pyke C, Græm N, Ralfkiær E, Rønne E, Heø-Hansen G, Brünner N, and Danø K (1993). Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 53:1911-1915.
43. Pyke C, Rømer J, Kallunki P, Lund LR, Ralfkiær E, Danø K, and Tryggvason K (1994). The gamma 2 chain of kalinin/ laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 145:782-791.
44. Rømer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, and Danø K (1996). Impaired wound healing in mice with a disrupted plasminogen gene. Nature Med 2:287-292.
45. Rønnov-Jessen L, Petersen OW, Koteliansky VE, and Bissel M (1995). The origin of the myofibroblasts in breast cancer: Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 95:859-873.
46. Rønnov-Jessen L, Petersen OW, and Bissel MJ (1996). Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction. Physiol Rev 76:69-125.
47. Salo T, Mäkelä M, Kylmäniemi M, Autio Harmainen H, and Larjava H (1994). Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 70: 176-182.
48. Sang Q-X, Birkedahl-Hansen H, and van Wart HE (1995). Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim Biophys Acta 1251:99-108.
49. Schlingemann RO, Rietveld FJR, de Waal RMW, Ferrone S, and Ruiter DJ (1990). Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and healing wounds. Am J Pathol 136:1393-1405.
50. Schlingemann RO, Rietveld FJR, Kwaspen F, van de Kerkhof PCM, de Waal RMW, and Ruiter DJ (1991). Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol 138:1335-1347.
51. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi, Murphy AN, Bird RE, Hoythya M, Fuerst TR, French DL, Quigley JP, and Kleinman HK (1993). Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 156:235-246.
52. Shepro D and Morel NML (1993). Pericyte physiology. FASEB J 7:1031-1038.
53. Shulman M, Wilde CD, and Köhler GA (1978). A better cell line for making hybridomas secreting specific antibodies. Nature 276:269.
54. Soini Y, Hurskainen T, Hoyhtya M, Oikarinen A, and Autio-Harmainen H (1994). 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: A study by in situ hybridization. J Histochem Cytochem 42: 945-951.
55. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, and Goldberg GI (1995). Mechanisms of cell surface activation of 72-kDa type IV collagenase. J Biol Chem 270:1-8.
56. Tarabolitte G, Garofalo A, Belotti D, Drudis T, Borsotti P, Scanziani E, Brown PD, and Giavazzi R (1995). Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst 87:293-298.
57. Teesalu T, Blasi F, and Talarico D (1996). Embryo implantation in mouse: Fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and alpha 2MR/LRP genes. Mech Dev 56:103-116.
58. Tryggvason K, Hoyhtya M, and Pyke C (1993). Type IV collagenases in invasive tumors. Breast Cancer Res Treat 24:209-218.
59. Urieli-Shoval S, Meek RL, Hansen RH, Ferguson M, Gordon D, and Benditt EP (1992). Preservation of RNA for in situ hybridization: Carnoy's versus formaldehyde fixation. J Histochem Cytochem 40:1879-1885.
60. Visscher DW, Hoyhtya M, Ottosen SK, Liang C-M, Sarkar FH, Crissman JD, and Fridman R (1994). Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 59:339-344.
61. Wesseling P, Schlingemann RO, Rietveld FJ, Link M, Burger PC, and Ruiter DJ (1995). Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: An immuno-light and immuno-electron microscopic study. J Neuropathol Exp Neurol 54:304-310.
62. Wolf C, Rouyer N, Lutz Y, Adida C, Loriot M, Bellocq JP, Chambon P, and Basset P (1993). Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci U S A 90:1843-1847.
63. Zucker S, Lysik RM, Zarrabi MH, and Moll U (1993). M(r) 92:000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 53:140-146.